secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001906324-24-000002
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q4 revenue $743M (-14% YoY); GAAP EPS $0.10, adj. EPS $1.17; FY24 guidance issued
--------------------------------------------------------------------------------

- Q4 revenue $743M vs $867M YoY; non-respiratory +9%, respiratory -49%.
- GAAP diluted EPS $0.10 (prior $0.45); adjusted diluted EPS $1.17 (prior $1.76).
- Full-year 2023 revenue $3.0B; GAAP diluted loss $0.15; adjusted EBITDA $723M (24% margin).
- FY24 guidance: revenue $2.76-3.07B; adj. EBITDA $565-720M; adj. EPS $2.40-3.07.
- Received 510(k) for Savanna multiplex platform and CLIA waiver for Sofia 2 SARS Antigen+ FIA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000002/0001906324-24-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000002/qdel-20240213.htm
  HTML page:      https://secwatch.observer/filing/0001906324-24-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer